Synthetic Cannabinoids: Illegal and Dangerous PDF Print E-mail
 BALTIMORE (August 28, 2012) – The Department of Health and Mental Hygiene (DHMH) advises Marylanders that a large number of Synthetic Cannabinoids, known by a variety of names such as “Spice” and “K2,” have been recently added to the federal list of Schedule 1 Controlled Substances. State and local health officials have long expressed concern about these products, which are marijuana-like synthetic compounds linked to potentially severe adverse reactions and abuse.
So far in 2012, the Maryland Poison Control has received 159 calls related to the use of Synthetic Cannabinoids, compared to a total of 151 calls in 2011.  More than half of the calls involved individuals age 19 or younger, and the calls have come from 20 of Maryland’s 24 counties.  Four involved admission to an Intensive Care Unit.

“Whether sold on the street or at a convenience store, synthetic cannabinoids pose a threat,” said Frances B. Phillips, Deputy Secretary for Public Health Services.  “This is another important topic for parents to discuss with their adolescents in order to protect their health.”

In January 2012, following a public comment period, the Department supported legislation to ban the sale of synthetic cannabinoids in Maryland. The recent federal action accomplishes this goal for Maryland and other states. 

Now that the sale of these products is illegal under federal law, the Department urges retailers to remove them from their shelves.

For more information: DEA: Nationwide Synthetic Drug Takedown

FBI Law Enforcement Bulletin: Synthetic Marijuana
Last Updated on Tuesday, 28 August 2012 11:40


Maryland urges residents to avoid use of synthetic marijuana, other illcit drugs. Lab-manufactured products often debilitate or kill, are sold as harmless household items.
Baltimore, MD (November 24, 2015) – The State of Maryland is urging residents to not use manufactured products known as synthetic cannabinoids – often called synthetic marijuana or the street names “Spice” and “K2” – or other illicit drugs. The substances have factored into a number of often-tragic incidents across the state.
Commission shares recommendation for Wash. Adventist Hospital relocation. The panel will consider proposal for $336 million project at its Dec. 17 meeting.
Baltimore, MD (November 19, 2015) – The Maryland Health Care Commission released a Recommended Decision in the matter of the proposed relocation of Washington Adventist Hospital (WAH),  a hospital owned and operated by Gaithersburg-based Adventist HealthCare (AHC).  WAH is currently located in Takoma Park (Montgomery County). The proposed site is in the White Oak area of Silver Spring at 12100 Plum Orchard Drive. The site is adjacent to US RT 29 and the ICC MD 200 and is part of the White Oak Science Gateway Master Plan.
State observes “Get Smart about Antibiotics” Week Nov. 16 through 22. Antibiotic resistance is worsened through misuse, overuse of prescriptions.
Baltimore, MD (November 16, 2015) – This week, the Maryland Department of Health and Mental Hygiene joins the U.S. Centers for Disease Control and Prevention, as well as many national and international partners, to observe the eighth annual “Get Smart About Antibiotics Week,” a weeklong initiative to raise awareness of antibiotic resistance and the importance of appropriate antibiotic prescribing and use.
 Lower Shore Health Insurance Assistance Program

           CLICK HERE

MD Cancer Fund 
Web Mastering by